Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents
Expert Opinion on Drug Safety August 28, 2023 DOI: 10.1080/14740338.2023.2253144 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | LSD Psilocybin Serotonin |
| Keywords | Psychotherapist Hallucinogen Pharmacology |
| Citations | 16 |
| Key findings | Psychedelics like psilocybin and LSD show promise as treatments for mood disorders, with FDA breakthrough therapy designation indicating a shift in their regulatory and therapeutic acceptance. |
Abstract
KEYWORDS: Psychedelicpsilocybinlysergic acid diethylamidemood disordersantidepressantsdiscoverypharmacologyFDA